These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15063084)

  • 1. Historical review: Cytokines as therapeutics and targets of therapeutics.
    Vilcek J; Feldmann M
    Trends Pharmacol Sci; 2004 Apr; 25(4):201-9. PubMed ID: 15063084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and anti-cytokines as therapeutics--an update.
    Tayal V; Kalra BS
    Eur J Pharmacol; 2008 Jan; 579(1-3):1-12. PubMed ID: 18021769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of anti-TNF therapy for rheumatoid arthritis.
    Feldmann M
    Nat Rev Immunol; 2002 May; 2(5):364-71. PubMed ID: 12033742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokines and their antagonists in the treatment of rheumatoid arthritis].
    Klimiuk PA; Sierakowski S
    Przegl Lek; 2002; 59(2):108-12. PubMed ID: 12152246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embracing novel cytokines in RA - complexity grows as does opportunity!
    Hueber AJ; Asquith DL; McInnes IB; Miller AM
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):479-87. PubMed ID: 20732646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO
    Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF alpha as a therapeutic target in rheumatoid arthritis.
    Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
    Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor and cancer treatment: a historical review and perspectives.
    Terlikowski SJ
    Rocz Akad Med Bialymst; 2001; 46():5-18. PubMed ID: 11780579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M; Maini RN
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
    Szekanecz Z; Szegedi G
    Orv Hetil; 1998 Apr; 139(14):819-23. PubMed ID: 9569729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Jones RE; Moreland LW
    Bull Rheum Dis; 1999; 48(3):1-4. PubMed ID: 10408141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in the treatment of malignancies.
    Jákó J; Arató G; Domján G; Hasitz A; Holló G; Petó M; Stélich G; Schopper J
    Acta Med Hung; 1994; 50(3-4):257-73. PubMed ID: 8587839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New cytokine targets in inflammatory rheumatic diseases.
    Connell L; McInnes IB
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):865-78. PubMed ID: 16980211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine and anti-cytokine strategies in inflammatory reaction modulation.
    Delannoy I; Lekeux P; Miossec P
    Vet Res; 1993; 24(6):449-67. PubMed ID: 8111428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
    Elliot MJ; Maini RN; Feldmann M; Long-Fox A; Charles P; Katasikis P; Brennan FM; Bijl H; Ghrayeb J; Woody JN
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S92-S101. PubMed ID: 18240199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
    Castor CW; Smith EM; Bignall MC; Hossler PA
    J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.